ArticleESMO open2021

Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge.

M Bono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.